Total Clarity Wealth Management’s Terns Pharmaceuticals TERN Stock Holding History

Total Clarity Wealth Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,950	Closed	-$208K	–	387
2026 Q1	$208K	Buy	+3,950	New	+$162K	0.05%	302

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Total Clarity Wealth Management's TERN Position: Q2 2026 in Review

Total Clarity Wealth Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 3,950 shares — an estimated $208K sold.

Total Clarity Wealth Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $208K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Total Clarity Wealth Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Total Clarity Wealth Management sold 3,950 Terns Pharmaceuticals shares in Q2 2026, an estimated $208K.
Total Clarity Wealth Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Total Clarity Wealth Management's Terns Pharmaceuticals position peaked at $208K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.